INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Open-market purchaseVerified data

Williams Gregg bought VANI

Director, 10% Owner · Vivani Medical, Inc. · Common Stock

Side
BUY
Value
$1.65M
Shares
1.47M
Price
$1.12
Executed
Nov 15, 2025
Disclosed
Nov 17, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 15 executedNov 17, 2025 disclosed

VANI · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
42/ 100 · ELEVATED
Methodology →
  • Transaction type+20 / 20

    Open-market purchase

  • Relative size+14 / 25

    $1.6M reported value · 6.9% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · VANI

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    12
    MA
    Mendelsohn AaronDirector
    VANIVivani Medical, Inc.
    Gift
    		G—
    20.0K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    9
    MJ
    Moretti August JDirector
    VANIVivani Medical, Inc.
    Grant or award
    		A$44K
    36.0K sh
    		Jun 24, 2026Jun 26, 2026
    traded Jun 24, 2026
    		+2dSEC FORM 4

    Evidence

    5
    MA
    Mendelsohn AaronDirector
    VANIVivani Medical, Inc.
    Grant or award
    		A$45K
    36.5K sh
    		Jun 24, 2026Jun 25, 2026
    traded Jun 24, 2026
    		+1dSEC FORM 4

    Evidence

    5
    WG
    Williams GreggDirector, 10% Owner
    VANIVivani Medical, Inc.
    Grant or award
    		A$45K
    36.5K sh
    		Jun 24, 2026Jun 25, 2026
    traded Jun 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    BD
    Bradbury DanielDirector
    VANIVivani Medical, Inc.
    Grant or award
    		A$45K
    36.5K sh
    		Jun 24, 2026Jun 25, 2026
    traded Jun 24, 2026
    		+1dSEC FORM 4

    Evidence

    9
    PL
    Popoff Alexandra L.Director
    VANIVivani Medical, Inc.
    Grant or award
    		A$45K
    36.5K sh
    		Jun 24, 2026Jun 25, 2026
    traded Jun 24, 2026
    		+1dSEC FORM 4

    Evidence

    38
    WG
    Williams GreggDirector, 10% Owner
    VANIVivani Medical, Inc.
    Open-market purchase
    		BUY$2.00M
    1.35M sh
    		Jan 27, 2026Jan 28, 2026
    traded Jan 27, 2026
    		+1dSEC FORM 4

    Evidence

    37
    WG
    Williams GreggDirector, 10% Owner
    VANIVivani Medical, Inc.
    Open-market purchase
    		BUY$333K
    264.6K sh
    		Jan 15, 2026Jan 20, 2026
    traded Jan 15, 2026
    		+5dSEC FORM 4

    Evidence

    44
    WG
    Williams GreggDirector, 10% Owner
    VANIVivani Medical, Inc.
    Open-market purchase
    		BUY$1.65M
    1.47M sh
    		Jan 15, 2026Jan 20, 2026
    traded Jan 15, 2026
    		+5dSEC FORM 4

    Evidence

    33
    MA
    Mendelsohn AaronDirector
    VANIVivani Medical, Inc.
    Open-market purchase
    		BUY$25K
    20.0K sh
    		Dec 29, 2025Dec 31, 2025
    traded Dec 29, 2025
    		+2dSEC FORM 4

    Evidence

    31
    MA
    Mendelsohn AaronDirector
    VANIVivani Medical, Inc.
    Gift
    		G—
    20.0K sh
    		Jul 8, 2024Dec 31, 2025
    traded Jul 8, 2024
    		+541dSEC FORM 4

    Evidence

    35
    WG
    Williams GreggDirector, 10% Owner
    VANIVivani Medical, Inc.
    Open-market purchase
    		BUY$333K
    264.6K sh
    		Nov 15, 2025Nov 17, 2025
    traded Nov 15, 2025
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001753926-25-001808
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Nov 15, 2025
    Published
    Nov 17, 2025
    Ingested by INSIDER
    Nov 5, 04:32 UTC
    Last re-read
    Nov 5, 04:32 UTC

    Extracted facts

    Filer
    Williams Gregg
    Role
    Director, 10% Owner
    Transaction
    Open-market purchaseAs filed: “P”
    Asset
    Vivani Medical, Inc.
    Ticker
    VANI
    Shares
    1.47M
    Price per share
    $1.12
    Value
    $1,650,000
    Execution date (reported)
    Nov 15, 2025
    Owned after transaction
    22.82M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 1.47M
    • Price: $1.12

    = $1,650,000

    What this establishes

    Williams Gregg filed this Form 4 reporting a open-market purchase of VANI on Nov 15, 2025. It became public on Nov 17, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, 10% Owner
    Williams Greggcik:0001624919
    Issuer
    Vivani Medical, Inc.cik:0001266806

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.